Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Lynch, Thomas J, Bell, Daphne W, Sordella, Raffaella, Gurubhagavatula, Sarada, Okimoto, Ross A, Brannigan, Brian W, Harris, Patricia L, Haserlat, Sara M, Supko, Jeffrey G, Haluska, Frank G, Louis, David N, Christiani, David C, Settleman, Jeff, Haber, Daniel A
Published in The New England journal of medicine (20.05.2004)
Published in The New England journal of medicine (20.05.2004)
Get full text
Journal Article
Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
BELL, Daphne W, LYNCH, Thomas J, KREBS, Annetta D, JOHNSON, David H, GIACCONE, Gmseppe, HERBST, Roy S, MANEGOLD, Christian, FUKUOKA, Masahiro, KRIS, Mark G, BASELGA, José, OCHS, Judith S, HABER, Daniel A, HASERLAT, Sara M, HARRIS, Patricia L, OKIMOTO, Ross A, BRANNIGAN, Brian W, SGROI, Dennis C, MUIR, Beth, RIEMENSCHNEIDER, Markus J, IACONA, Renee Bailey
Published in Journal of clinical oncology (01.11.2005)
Published in Journal of clinical oncology (01.11.2005)
Get full text
Journal Article
Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas
KWAK, Eunice L, JANKOWSKI, Janusz, MUIR, Beth, SETTLEMAN, Jeff, FUCHS, Charles S, KULKE, Matthew H, RYAN, David P, CLARK, Jeff W, SGROI, Dennis C, HABER, Daniel A, BELL, Daphne W, THAYER, Sarah P, LAUWERS, Gregory Y, BRANNIGAN, Brian W, HARRIS, Patricia L, OKIMOTO, Ross A, HASERLAT, Sara M, DRISCOLL, David R, FERRY, David
Published in Clinical cancer research (15.07.2006)
Published in Clinical cancer research (15.07.2006)
Get full text
Journal Article
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias
Kim, Woo Jae, Okimoto, Ross A., Purton, Louise E., Goodwin, Meagan, Haserlat, Sara M., Dayyani, Farshid, Sweetser, David A., McClatchey, Andrea I., Bernard, Olivier A., Look, A. Thomas, Bell, Daphne W., Scadden, David T., Haber, Daniel A.
Published in Blood (01.05.2008)
Published in Blood (01.05.2008)
Get full text
Journal Article
Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of ERBB2 rather than EGFR
COHEN, Ezra E. W, LINGEN, Mark W, CLARK, John R, ROCCO, James W, VOKES, Everett E, HABER, Daniel A, BELL, Daphne W, MARTIN, Leslie E, HARRIS, Patricia L, BRANNIGAN, Brian W, HASERLAT, Sara M, OKIMOTO, Ross A, SGROI, Dennis C, DAHIYA, Sonika, MUIR, Beth
Published in Clinical cancer research (15.11.2005)
Published in Clinical cancer research (15.11.2005)
Get full text
Journal Article
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts
Bell, Daphne W., Kim, Sang H., Godwin, Andrew K., Schiripo, Taryn A., Harris, Patricia L., Haserlat, Sara M., Wahrer, Doke C.R., Haiman, Christopher A., Daly, Mary B., Niendorf, Kristin B., Smith, Matthew R., Sgroi, Dennis C., Garber, Judy E., Olopade, Olufunmilayo I., Marchand, Loic Le, Henderson, Brian E., Altshuler, David, Haber, Daniel A., Freedman, Matthew L.
Published in International journal of cancer (15.12.2007)
Published in International journal of cancer (15.12.2007)
Get full text
Journal Article
Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin
Zhang, Jianmin, Song, Young-Han, Brannigan, Brian W, Wahrer, Doke C R, Schiripo, Taryn A, Harris, Patricia L, Haserlat, Sara M, Ulkus, Lindsey E, Shannon, Kristen M, Garber, Judy E, Freedman, Matthew L, Henderson, Brian E, Zou, Lee, Sgroi, Dennis C, Haber, Daniel A, Bell, Daphne W
Published in Molecular cancer research (01.09.2009)
Published in Molecular cancer research (01.09.2009)
Get full text
Journal Article
Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis
SMOLEN, Gromoslaw A, MUIR, Beth, GARBER, Judy E, BELL, Daphne W, SGROI, Dennis C, CHIN, Lynda, DENG, Chu-Xia, HABER, Daniel A, MOHAPATRA, Gayatry, BARMETTLER, Anne, KIM, Woo J, RIVERA, Miguel N, HASERLAT, Sara M, OKIMOTO, Ross A, KWAK, Eunice, DAHIYA, Sonika
Published in Cancer research (Chicago, Ill.) (01.04.2006)
Published in Cancer research (Chicago, Ill.) (01.04.2006)
Get full text
Journal Article
Abstract 4972: Preclinical development of a first-in-class NKp30xBCMA NK cell engager for the treatment of multiple myeloma
Draghi, Monia, Schafer, Jamie L., Nelson, Allison, Frye, Zach, Oliphant, Amanda, Haserlat, Sara, Lajoie, jason, rogers, Kenneth, Villinger, Francois, Schmidt, Michael, Tighe, Robert, Bobrowicz, Piotr, Watkins-Yoon, Jennifer, Schuetz, Thomas
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 3239: CTX-5861 mediated SIRPα blockade combines with tumor targeting antibodies, checkpoint blockade and/or CD137 agonism to elicit curative anti-tumor activity in syngeneic mouse models
Eskiocak, Ugur, Guzman, Wilson, Daly, Thomas, Nelson, Allison, Bakhru, Pearl, Lajoie, Jason, Haserlat, Sara, Ottinger, Samantha, Liu, Lucy, Oliphant, Amanda, Leung, Alan, Hemashettar, Girish, Rennard, Rachel, Wolf, Benjamin, Draghi, Monia, Schmidt, Michael, Tighe, Robert
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
CTX-8573, an Innate-Cell Engager Targeting BCMA, is a Highly Potent Multispecific Antibody for the Treatment of Multiple Myeloma
Watkins-Yoon, Jennifer, Guzman, Wilson, Oliphant, Amanda, Haserlat, Sara, Leung, Alan, Chottin, Claire, Ophir, Michael, Vekeria, Jai, Nelson, Allison P, Frye, Zach, Lajoie, Jason, Nanjappa, Puru, Lama, Sujan, Markrush, Dalton, McConaughy, William, Wang, Xianzhe, Schilling, Neal, Kim, Doyeob, Wu, Paul, Liu, Lucy, Rogers, Kenneth, Villinger, Francois, Gong, Bing, Hamilton, Stephen, Bobrowicz, Piotr, Schuetz, Thomas, Schmidt, Michael, Draghi, Monia
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Abstract 4586: Essential role of fibroblast growth factor receptor 2 (FGFR2) in tumorigenesis of human cancers with activated FGFR2 signaling demonstrated by functional blocking antibodies
Bai, Ailin, Meetze, Kristan, Vo, Nhi Y., Kollipara, Sriram, Mazsa, Elizabeth K., Winston, William M., Weiler, Solly, Poling, Laura L., Chen, Ting, Haserlat, Sara, Abbott, Sandra, Tissire, Hamid, DiPrima, Michael, Ismail, Nesreen S., Jiang, Jinwei, Lerner, Lorena, Gyuris, Jeno, Weng, Zhigang
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
ANTI-FGFR2 ANTIBODIES
ISMAIL, NESREEN, WEILER, SOLLY, MAZSA, ELIZABETH, WENG, ZHIGANG, MEETZE, KRISTAN, POLING, LAURA, WINSTON, WILLIAM, J, HASERLAT, SARA, TISSIRE, HAMID, GYURIS, JENO, BAI, AILIN, CHEN, TING
Year of Publication 12.06.2014
Get full text
Year of Publication 12.06.2014
Patent